Table 3 Comparison of demographic and hematological parameters between methotrexate-only and methotrexate with surgery groups.

From: The relationship between hemogram based inflammatory indices and prognosis in ectopic pregnancy cases treated with methotrexate

 

Metotrexate

(n = 71)

Mtx and surgery

(n = 14)

p value

Mean ± S.D.

Mean ± S.D.

Age (years)

31.8 ± 6.0

32.5 ± 7.6

0.687 b

BMI (kg/m2)

25.07 ± 3.97

24.03 ± 3.5

0.362 a

Parity

0.8 ± 0.9

0.9 ± 0.9

0.441 b

WBC (103/µL)

8.39 ± 2.18

8.82 ± 2.6

0.516 a

Hemoglobin (g/dL)

12.5 ± 1.3

12.6 ± 1.4

0.948 b

Hematocrit (%)

37.9 ± 3.6

37.6 ± 3.5

0.813 a

Lymphocyte (103/µL)

2.35 ± 0.73

2.36 ± 0.8

0.951 a

Monocyte (103/µL)

0.62 ± 0.9

0.50 ± 0.2

0.619 b

Neutrophil (103/µL)

5.37 ± 1.95

5.76 ± 2.5

0.803 b

Platelet (103/µL)

281.9 ± 57.3

290.9 ± 39.4

0.580 a

Admission β-hCG

2301.5 ± 3140.4

4721.1 ± 5647.8

0.098 b

MTX day β-hCG

2563.0 ± 3437.2

5787.1 ± 6216.2

0.054 b

MTX day 4 β-hCG

2534.9 ± 3844.8

12369.6 ± 11597.6

0.003 b

MTX day 7 β-hCG

1780.2 ± 3348.4

11899.3 ± 10605.3

< 0.001 b

NLR

2.70 ± 2.8

3.03 ± 3.2

0.813 b

MLR

0.26 ± 0.28

0.24 ± 0.18

0.740 b

PLR

134.00 ± 63.8

140.63 ± 67.3

0.804 b

SII

136.43 ± 71.9

131.52 ± 52.3

0.813 b

  1. Data are presented as mean ± standard deviation.
  2. BMI: Body Mass Index, WBC: White Blood Cell Count, NLR: Neutrophil-to-Lymphocyte Ratio, MLR: Monocyte-to-Lymphocyte Ratio, PLR: Platelet-to-Lymphocyte Ratio, SII: Systemic Immune-Inflammation Index, β-hCG: Beta-Human Chorionic Gonadotropin.
  3. aIndependent Samples t-test, bMann-Whitney U test. Statistically significant p-values are highlighted in bold.
Back to article page